As interest in kratom grows globally, the question arises: Is kratom legal in Germany? This article delves into the current Kratom regulation in Germany (2025)—examining statutes, recent developments, regulatory agencies, and practical advice for consumers and businesses. With clear focus on the keyword “Kratom regulation in Germany,” you’ll gain insights into where the laws stand today, what’s changing, and how to stay compliant.
Kratom is not listed under Germany’s Narcotics Act (Betäubungsmittelgesetz, BtMG), meaning possession and trade are not criminalized. The Higher Regional Court of Cologne ruled on 11 September 2015 that kratom does not qualify as a medicinal product, clarifying that its commercial sale and use remain legal .
Under current German regulations, kratom must not be marketed for human consumption—products usually carry warnings like “not suitable for human consumption”. Failing to include this labeling may trigger enforcement actions under food and consumer protection laws .
Kratom qualifies as a novel food under EU Regulation 2015/2283, since it wasn’t in EU use pre-May 1997. This designation prohibits its sale as an edible product unless it completes EFSA safety assessment and receives approval .
The BfArM has repeatedly reviewed kratom’s legal classification (e.g., December 2023) and may consider listing it under the New Psychoactive Substances Act (NpSG). Currently, it remains unlisted under BtMG and AMG.
As a novel food, kratom must clear EU-level risk assessments. Imports are monitored under the Lisbon Treaty customs regime. Currently, shipments from kratom-legal EU countries are permitted, but kratom cannot be labelled as food or supplement.
Enforcement can vary among Germany’s federal states (“Länder”). Some regions may adopt stricter interpretations, while others follow BfArM’s guidance. Urban centers like Berlin and Frankfurt tend to exhibit looser enforcement. Labeling compliance remains key to remaining lawful .
Following Belgium’s ban in 2024, BfArM and their expert committee reopened discussions on listing kratom under psychoactive controlled substances . Public concern, petitions, and debates are ongoing.
“Germany mulls Kratom prohibition… act now!”
Several communities, especially via the European Kratom Alliance (EKA), have launched petitions and surveys urging reform.
The EKA encourages users to share testimonials and participate in parliamentary feedback, with about 1.5 million German kratom users cited in surveys .
A key debate is whether kratom can be regulated like a supplement, a novel food, or should become a controlled substance. Progress in the Czech Republic toward GMP-regulated kratom (effective Jan 2025) provides inspiration for Germany’s discussions.
| Region | Legal Status | Notes |
|---|---|---|
| Germany | Legal w/ restrictions | Labeling mandatory, consumption grey, possible NpSG inclusion |
| EU | Varies by country | Belgium banned; Czech moving toward regulated framework |
| USA | Legal federally, states vary | Often regulated via American Kratom Association |
| Canada | Restricted (no ingestible) | Non-consumable products only |
| Thailand | Fully legal medicinally | Legislation passed in 2018 liberally |
Continuously monitor BfArM bulletins, EKA announcements, and state-level health ministries.
Craft labels that clearly state “Not for human consumption.” Avoid any health or supplement claims.
Support EKA petitions, surveys, and awareness platforms to influence policies.
If EFSA clears kratom as a novel food, it may open legal sales—but remember strict GMP and safety testing apply.
Kratom regulation in Germany remains a complex, shifting landscape. Currently legal if labelled and sold as non-consumable, kratom sits in a legal grey zone with active scrutiny from BfArM and increasing public involvement. Petitions, expert committee reviews, and EU-level moves like GMP frameworks suggest 2025 could bring significant regulation or more freedom—depending on advocacy strength.
For consumers and retailers, vigilance is key: comply with current labeling rules, monitor new regulations, and support advocacy efforts that encourage balanced, science-based regulation.
Related Articles
WhatsApp us